Cocrystal Pharma (COCP) Cash from Financing Activities (2010 - 2025)
Cocrystal Pharma (COCP) reported Cash from Financing Activities of $1.0 million for Q4 2025, down 74.2% sequentially from $4.0 million in Q2 2023.
Cocrystal Pharma (COCP) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Cocrystal Pharma (COCP) has 14 years of Cash from Financing Activities data on file, last reported at $1.0 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2025 stood at $5.0 million (changed N/A YoY), and the FY2025 full-year result was $5.4 million, changed N/A from the prior year.
- Cash from Financing Activities eased to $1.0 million in Q4 2025, from $4.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $36.4 million in Q2 2021 to a low of -$11000.0 in Q3 2021.
- A 4-year average of $4.0 million and a median of -$7000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities soared 82879.55% in 2021 and sank 100.29% in 2022, its largest moves.
- Tracing COCP's Cash from Financing Activities over 4 years: stood at -$9000.0 in 2021, then rose by 22.22% to -$7000.0 in 2022, then soared by 57242.86% to $4.0 million in 2023, then sank by 74.2% to $1.0 million in 2025.
- Business Quant data shows COCP's Cash from Financing Activities at $1.0 million in Q4 2025, $4.0 million in Q2 2023, and -$7000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 53,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 68.63 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 238.74 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.03 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Jun 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 4.00 Mn |
| Mar 31, 2023 | -7,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -7,000.00 |
| Dec 31, 2022 | -7,000.00 |
| Sep 30, 2022 | -7,000.00 |
| Sep 30, 2022 | -7,000.00 |
| Jun 30, 2022 | -7,000.00 |
| Jun 30, 2022 | -7,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Sep 30, 2021 | -11,000.00 |
| Sep 30, 2021 | -11,000.00 |
| Jun 30, 2021 | 36.42 Mn |
| Jun 30, 2021 | 36.42 Mn |